Transcripts

Acadia Pharmaceuticals (ACAD) earnings call transcripts

Earnings call transcripts for Acadia Pharmaceuticals Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Commercial momentum, especially sticks, strengthened confidence while Europe and a binary ADP readout define the next catalysts. 40% of U.S.

    Aug 04, 2026Confident0.82